Dedicated to Neurological Discoveries
Dysport® is the Botulinum toxin A of choice.
That will enable specialists to confidently and safely treat patients with spasticity placed under their care.
Dysport® is a highly purified Botulinum toxin A formulation with a field proven efficacy and safety profile. It is supported by innovative clinical and training programs that create trust and opportunities for mutual sharing of experience and expertise among specialists resulting in ongoing improvement of patient outcomes.
Spasticity is one of the most disabling problems in neurological rehabilitation. It is one of the most important factors involving in a motor movement and its control. It can lead to physical impairments and disabilities e.g. pain and discomfort, limited range of joint movement and joint contractures, difficulty doing activities of daily livings, walking, and nursing care. Treatment is generally aimed at improving postures and function, facilitating physiotherapy, positioning with appropriate seating, orthoses, oral medication, chemical neurolysis with phenol, alcohol or Botulinum toxin, intrathecal baclofen and surgery.
The clinical effect of Boltulinum toxin has been recognized for more than hundred years. Botulinum toxin presynaptically blocks acetylcholine release at the neuromuscular junction in a long-lasting but reversible fashion. Botulinum toxin-A (BTA) has been in clinical use for two decades with an outstanding efficacy and safety profile. Botulinum toxin-A is currently used worldwide for various conditions such as movement disorders, spasticity, and other conditions associated with abnormal muscle contractions.
Click here for more of Dysport®’s prescribing information
